BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 7892294)

  • 21. Estrogenic and antiproliferative activities of isoliquiritigenin in MCF7 breast cancer cells.
    Maggiolini M; Statti G; Vivacqua A; Gabriele S; Rago V; Loizzo M; Menichini F; Amdò S
    J Steroid Biochem Mol Biol; 2002 Nov; 82(4-5):315-22. PubMed ID: 12589938
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of estrogen action by 2-phenylchromone as AhR agonist in MCF-7 cells.
    Jung J; Ishida K; Nishikawa J; Nishihara T
    Life Sci; 2007 Oct; 81(19-20):1446-51. PubMed ID: 17950758
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synergistic activation of estrogen receptor with combinations of environmental chemicals.
    Arnold SF; Klotz DM; Collins BM; Vonier PM; Guillette LJ; McLachlan JA
    Science; 1996 Jun; 272(5267):1489-92. PubMed ID: 8633243
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Estrogenic activity of octylphenol, nonylphenol, bisphenol A and methoxychlor in rats.
    Laws SC; Carey SA; Ferrell JM; Bodman GJ; Cooper RL
    Toxicol Sci; 2000 Mar; 54(1):154-67. PubMed ID: 10746942
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential activation of wild-type and variant forms of estrogen receptor alpha by synthetic and natural estrogenic compounds using a promoter containing three estrogen-responsive elements.
    Yoon K; Pallaroni L; Stoner M; Gaido K; Safe S
    J Steroid Biochem Mol Biol; 2001 Jul; 78(1):25-32. PubMed ID: 11530281
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 4-ethoxymethylphenol: a novel phytoestrogen that acts as an agonist for human estrogen receptors.
    Pearce V; Nawaz Z; Xiao W; Wiedenfeld D; Boyle N; Smith D
    J Steroid Biochem Mol Biol; 2003 Mar; 84(4):431-9. PubMed ID: 12732288
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of an array of in vitro assays for the assessment of the estrogenic potential of natural and synthetic estrogens, phytoestrogens and xenoestrogens.
    Gutendorf B; Westendorf J
    Toxicology; 2001 Sep; 166(1-2):79-89. PubMed ID: 11518614
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evidence for estrogenic contamination of the MAPK inhibitor PD98059.
    Long X; Gize EA; Nephew K; Bigsby RM
    Endocrinology; 2001 Dec; 142(12):5390-3. PubMed ID: 11713241
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The molecular mechanisms of estrogens. Clinical aspects, industrial estrogens and phytoestrogens].
    Hagen ML; Hellmers M; Abrahamsen B; Hagen C
    Ugeskr Laeger; 2004 Mar; 166(13):1220-4. PubMed ID: 15088482
    [No Abstract]   [Full Text] [Related]  

  • 30. Estrogenic activity of natural and synthetic estrogens in human breast cancer cells in culture.
    Zava DT; Blen M; Duwe G
    Environ Health Perspect; 1997 Apr; 105 Suppl 3(Suppl 3):637-45. PubMed ID: 9168008
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plant estrogens and human health.
    Michnovicz JJ
    Ann Surg Oncol; 1996 Nov; 3(6):513-4. PubMed ID: 8915480
    [No Abstract]   [Full Text] [Related]  

  • 32. Bisphenol a binds to the low-affinity estrogen binding site.
    Washington W; Hubert L; Jones D; Gray WG
    In Vitr Mol Toxicol; 2001; 14(1):43-51. PubMed ID: 11689155
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Studies of structure-activity relationship on plant polyphenol-induced suppression of human liver cancer cells.
    Loa J; Chow P; Zhang K
    Cancer Chemother Pharmacol; 2009 May; 63(6):1007-16. PubMed ID: 18766342
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Requirement of metabolic activation for estrogenic activity of Pueraria mirifica.
    Lee YS; Park JS; Cho SD; Son JK; Cherdshewasart W; Kang KS
    J Vet Sci; 2002 Dec; 3(4):273-7. PubMed ID: 12819377
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Estrogen receptor alpha mediates the proliferative but not the cytotoxic dose-dependent effects of two major phytoestrogens on human breast cancer cells.
    Maggiolini M; Bonofiglio D; Marsico S; Panno ML; Cenni B; Picard D; Andò S
    Mol Pharmacol; 2001 Sep; 60(3):595-602. PubMed ID: 11502892
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Estrogen-like properties of brominated analogs of bisphenol A in the MCF-7 human breast cancer cell line.
    Samuelsen M; Olsen C; Holme JA; Meussen-Elholm E; Bergmann A; Hongslo JK
    Cell Biol Toxicol; 2001; 17(3):139-51. PubMed ID: 11693576
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Flavonoid effects relevant to cancer.
    Brownson DM; Azios NG; Fuqua BK; Dharmawardhane SF; Mabry TJ
    J Nutr; 2002 Nov; 132(11 Suppl):3482S-3489S. PubMed ID: 12421874
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effective free fraction of estradiol and xenoestrogens in human serum measured by whole cell uptake assays: physiology of delivery modifies estrogenic activity.
    Nagel SC; vom Saal FS; Welshons WV
    Proc Soc Exp Biol Med; 1998 Mar; 217(3):300-9. PubMed ID: 9492339
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of estrogenicity of phytoestrogens in an endometrial-derived experimental model.
    Hopert AC; Beyer A; Frank K; Strunck E; Wünsche W; Vollmer G
    Environ Health Perspect; 1998 Sep; 106(9):581-6. PubMed ID: 9721258
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New screening methods for chemicals with hormonal activities using interaction of nuclear hormone receptor with coactivator.
    Nishikawa J; Saito K; Goto J; Dakeyama F; Matsuo M; Nishihara T
    Toxicol Appl Pharmacol; 1999 Jan; 154(1):76-83. PubMed ID: 9882594
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.